Lantheus Holdings Revenue 2013-2024 | LNTH

Lantheus Holdings annual/quarterly revenue history and growth rate from 2013 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Lantheus Holdings revenue for the quarter ending December 31, 2024 was $0.391B, a 10.48% increase year-over-year.
  • Lantheus Holdings revenue for the twelve months ending December 31, 2024 was $1.534B, a 18.32% increase year-over-year.
  • Lantheus Holdings annual revenue for 2024 was $1.534B, a 18.32% increase from 2023.
  • Lantheus Holdings annual revenue for 2023 was $1.296B, a 38.65% increase from 2022.
  • Lantheus Holdings annual revenue for 2022 was $0.935B, a 119.91% increase from 2021.
Lantheus Holdings Annual Revenue
(Millions of US $)
2024 $1,534
2023 $1,296
2022 $935
2021 $425
2020 $339
2019 $347
2018 $343
2017 $331
2016 $302
2015 $293
2014 $302
2013 $284
2012 $288
Lantheus Holdings Quarterly Revenue
(Millions of US $)
2024-12-31 $391
2024-09-30 $379
2024-06-30 $394
2024-03-31 $370
2023-12-31 $354
2023-09-30 $320
2023-06-30 $322
2023-03-31 $301
2022-12-31 $263
2022-09-30 $239
2022-06-30 $224
2022-03-31 $209
2021-12-31 $130
2021-09-30 $102
2021-06-30 $101
2021-03-31 $93
2020-12-31 $94
2020-09-30 $89
2020-06-30 $66
2020-03-31 $91
2019-12-31 $89
2019-09-30 $86
2019-06-30 $86
2019-03-31 $87
2018-12-31 $86
2018-09-30 $89
2018-06-30 $86
2018-03-31 $83
2017-12-31 $81
2017-09-30 $80
2017-06-30 $89
2017-03-31 $81
2016-12-31 $74
2016-09-30 $73
2016-06-30 $78
2016-03-31 $76
2015-12-31 $71
2015-09-30 $74
2015-06-30 $73
2015-03-31 $75
2014-12-31
2014-09-30 $76
2014-06-30 $76
2013-12-31
2012-12-31
Sector Industry Market Cap Revenue
Medical MED PRODUCTS $7.447B $1.534B
Lantheus Holdings, Inc. is involved in developing, manufacturing, selling and distributing diagnostic medical imaging agents and products for diagnosis of cardiovascular and other diseases. It serves to hospitals, clinics, group practices, integrated delivery networks, group purchasing organizations, radiopharmacies and wholesalers. Lantheus Holdings, Inc. is based in NORTH BILLERICA, United States.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) US $231.085B 27.79
Boston Scientific (BSX) US $155.238B 38.86
Stryker (SYK) US $144.362B 30.18
EssilorLuxottica (ESLOY) FR $132.860B 0.00
Medtronic (MDT) IE $108.824B 15.89
Lonza Group Ag (LZAGY) CH $52.624B 0.00
Haleon (HLN) GB $48.259B 27.44
ResMed (RMD) US $35.183B 26.43
GE HealthCare Technologies (GEHC) US $32.295B 15.33
Agilent Technologies (A) US $30.971B 20.46
Terumo (TRUMY) JP $29.019B 0.00
Koninklijke Philips (PHG) NL $24.053B 17.17
Zimmer Biomet Holdings (ZBH) US $20.255B 12.80
Insulet (PODD) US $18.084B 77.18
Baxter (BAX) US $15.752B 11.77
Smith & Nephew SNATS (SNN) GB $12.535B 0.00
Sunny Optical Technology (SNPTF) CN $9.032B 0.00
Demant (WILYY) DK $7.970B 0.00
Bio-Rad Laboratories (BIO) US $6.620B 22.38
Prestige Consumer Healthcare (PBH) US $4.171B 19.90
Perrigo (PRGO) IE $3.497B 10.01
ICU Medical (ICUI) US $3.486B 29.69
Shandong Weigao Medical Polymer (SHWGF) CN $3.459B 0.00
Haemonetics (HAE) US $3.208B 15.10
Envista Holdings (NVST) US $2.880B 23.93
GN Store Nord (GNNDY) DK $2.068B 17.13
QuidelOrtho (QDEL) US $1.964B 16.45
LeMaitre Vascular (LMAT) US $1.778B 39.75
AtriCure (ATRC) US $1.486B 0.00
Green Thumb Industries (GTBIF) US $1.374B 21.63
Neogen (NEOG) US $1.248B 15.97
Kestra Medical Technologies (KMTS) US $1.220B 0.00
BioLife Solutions (BLFS) US $1.200B 0.00
AdaptHealth (AHCO) US $1.184B 11.40
InMode (INMD) IL $1.013B 9.28
Phibro Animal Health (PAHC) US $0.789B 12.10
Evolus (EOLS) US $0.779B 0.00
Curaleaf Holdings (CURLF) CA $0.637B 0.00
CeriBell (CBLL) US $0.588B 0.00
Owens & Minor (OMI) US $0.580B 4.94
Valneva SE (VALN) FR $0.549B 0.00
Capricor Therapeutics (CAPR) US $0.542B 0.00
Maravai LifeSciences Holdings (MRVI) US $0.526B 0.00
Tilray Brands (TLRY) CA $0.458B 0.00
Cresco Labs (CRLBF) US $0.442B 0.00
Omeros (OMER) US $0.418B 0.00
Surmodics (SRDX) US $0.395B 0.00
SNDL (SNDL) CA $0.365B 0.00
VAREX IMAGING (VREX) US $0.359B 15.55
SEMPERIT AG HLD (SEIGY) AT $0.317B 0.00
Verano Holdings (VRNOF) US $0.296B 0.00
Sanara MedTech (SMTI) US $0.292B 0.00
Viemed Healthcare (VMD) US $0.291B 26.32
Aurora Cannabis (ACB) CA $0.272B 48.40
Sanuwave Health (SNWV) US $0.264B 0.00
ZimVie (ZIMV) US $0.261B 15.60
Cerus (CERS) US $0.258B 0.00
Canopy Growth (CGC) CA $0.245B 0.00
Quanterix (QTRX) US $0.233B 0.00
OraSure Technologies (OSUR) US $0.231B 0.00
High Tide (HITI) CA $0.194B 0.00
Biote (BTMD) US $0.190B 4.35
Utah Medical Products (UTMD) US $0.173B 13.93
Brainsway (BWAY) IL $0.170B 53.06
TriSalus Life Sciences (TLSI) US $0.165B 0.00
Organigram Global (OGI) CA $0.154B 0.00
FitLife Brands (FTLF) US $0.148B 18.22
Jin Medical (ZJYL) CN $0.119B 0.00
TerrAscend (TSNDF) CA $0.116B 0.00
MacroGenics (MGNX) US $0.110B 0.00
Exagen (XGN) US $0.108B 0.00
Agape ATP (ATPC) $0.099B 0.00
Oramed Pharmaceuticals (ORMP) US $0.095B 0.00
Quipt Home Medical (QIPT) US $0.094B 0.00
Fonar (FONR) US $0.076B 10.70
Jushi Holdings (JUSHF) US $0.076B 0.00
Veru (VERU) US $0.075B 0.00
InterCure (INCR) IL $0.073B 0.00
Zynex (ZYXI) US $0.070B 0.00
United Health Products (UEEC) US $0.064B 0.00
Cytosorbents (CTSO) US $0.059B 0.00
ImmuCell (ICCC) US $0.048B 0.00
Apyx Medical (APYX) US $0.047B 0.00
Modular Medical (MODD) US $0.042B 0.00
Rockwell Medical (RMTI) US $0.042B 61.50
United-Guardian (UG) US $0.037B 11.28
Safety Shot (SHOT) US $0.036B 0.00
Nephros (NEPH) US $0.020B 0.00
INLIF (INLF) $0.018B 0.00
Trinity Biotech (TRIB) IE $0.015B 0.00
Cellectar Biosciences (CLRB) US $0.012B 0.00
Flora Growth (FLGC) US $0.012B 0.00
Allurion Technologies (ALUR) US $0.011B 0.00
NeuroMetrix (NURO) US $0.009B 0.00
Meihua Medical Technologies (MHUA) CN $0.007B 0.00
Innovative Eyewear (LUCY) US $0.005B 0.00
GlucoTrack (GCTK) US $0.004B 0.00
Senestech (SNES) US $0.004B 0.00
IM Cannabis (IMCC) CA $0.004B 0.00
Akanda (AKAN) GB $0.002B 0.00
Sharps Technology (STSS) US $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) US $0.000B 0.00